Cargando…
Glyoxalase 1 Prevents Chronic Hyperglycemia Induced Heart-Explant Derived Cell Dysfunction
Decades of work have shown that diabetes increases the risk of heart disease and worsens clinical outcomes after myocardial infarction. Because diabetes is an absolute contraindication to heart transplant, cell therapy is increasingly being explored as a means of improving heart function for these p...
Autores principales: | Villanueva, Melanie, Michie, Connor, Parent, Sandrine, Kanaan, Georges N, Rafatian, Ghazaleh, Kanda, Pushpinder, Ye, Bin, Liang, Wenbin, Harper, Mary-Ellen, Davis, Darryl R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735395/ https://www.ncbi.nlm.nih.gov/pubmed/31534514 http://dx.doi.org/10.7150/thno.36639 |
Ejemplares similares
-
Mybl2 rejuvenates heart explant‐derived cells from aged donors after myocardial infarction
por: Rafatian, Ghazaleh, et al.
Publicado: (2020) -
Electrophysiological engineering of heart-derived cells with calcium-dependent potassium channels improves cell therapy efficacy for cardioprotection
por: Vigneault, Patrick, et al.
Publicado: (2021) -
Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells
por: Mayfield, Audrey E, et al.
Publicado: (2017) -
Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium
por: Mount, Seth, et al.
Publicado: (2019) -
Glyoxalase Goes Green: The Expanding Roles of Glyoxalase in Plants
por: Sankaranarayanan, Subramanian, et al.
Publicado: (2017)